Overview

Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults

Status:
Completed
Trial end date:
2017-08-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of four different doses of cytomegalovirus vaccines in healthy adults.
Phase:
Phase 1
Details
Lead Sponsor:
VBI Vaccines Inc.
Collaborators:
Clinical Trial Data Services, LLC
Virginia Commonwealth University
Treatments:
Vaccines